Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification and Evaluation of the Potential Biomarkers on Circulating Tumor Cells and Tumor Related Rare Cells in Cancer Patients Undergoing Immunotherapy

NCT03434912 is registered in ClinicalTrials.gov with MiCareo Taiwan Co., Ltd. as lead sponsor.

NCT NCT03434912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03434912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification and Evaluation of the Potential Biomarkers on Circulating Tumor Cells and Tumor Related Rare Cells in Cancer Patients Undergoing Immunotherapy
Lead sponsor
MiCareo Taiwan Co., Ltd.
Phase
Observational
Overall status
Unknown status
Start date
May 24, 2017
Completion date
April 30, 2020
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ctc and tumor related rare cell